Table 2 Antimicrobial susceptibility patterns of 58 Aeromonads separated from bacteremia
Antimicrobial agent | CLSI breakpoint interpretation (%) | MIC50 | MIC range | ||
|---|---|---|---|---|---|
S | I | R | |||
Ceftazidime | 88 | 1.7 | 10.3 | ≤ 1 | ≤ 1 ~ ≥ 64 |
Cefotetan | 86.2 | 0 | 13.8 | ≤ 4 | ≤ 4 ~ ≥ 64 |
Ceftriaxone | 79.3 | 5.2 | 15.5 | ≤ 1 | ≤ 1 ~ ≥ 64 |
Cefepime | 98.3 | 0 | 1.7 | ≤ 1 | ≤ 1 ~ 32 |
Piperacillin/tazobactam | 88 | 1.7 | 10.3 | ≤ 4 | ≤ 4 ~ ≥ 128 |
Aztreonam | 91.4 | 3.4 | 5.2 | ≤ 1 | ≤ 1 ~ ≥ 64 |
Imipenem | 75.9 | 10.3 | 13.8 | ≤ 1 | ≤ 1 ~ ≥ 16 |
Levofloxacin | 96.6 | 1.7 | 1.7 | ≤ 0.25 | ≤ 0.25 ~ ≥ 8 |
Ciprofloxacin | 96.6 | 0 | 3.4 | ≤ 0.25 | ≤ 0.25 ~ ≥ 4 |
TRIMETHOPRIM/sulfamethoxazole | 87.9 | 0 | 12.1 | ≤ 20 | ≤ 20 ~ ≥ 320 |
Amikacin | 100 | 0 | 0 | ≤ 2 | ≤ 2 |
Gentamicin | 100 | 0 | 0 | ≤ 1 | ≤ 1 |
Tobramycin | 93.1 | 5.2 | 1.7 | ≤ 1 | ≤ 1 ~ ≥ 16 |
Furantoin | 100 | 0 | 0 | ≤ 16 | ≤ 16 |